Who knows? Frustrating that the news we all seem to be holding out for is first patient dosed in burns trial and first patient dosed in sepsis iv trial. From what I read burns may or may not be happening currently, update seems to avoid mentioning start of dosing has occurred? Maybe because if they confirm start they would then be obliged to announce "something" weeks later? Iv sepsis still appears to be months away? Surely they know what the market wants to know, why can't it be stated? Have patients been treated for burns yet? When will first patient be dosed for iv trial that is running in parallel with burns trial? Any issues causing the delay? I guess it is fairly standard that nothing starts on time and obviously a lot of work required to get things started in a stage 1 medical trial of a new drug as yet still to be confirmed as safe in humans.
RCE Price at posting:
$1.07 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)